LEADER 00761nam0-22002771i-450- 001 990003015260403321 035 $a000301526 035 $aFED01000301526 035 $a(Aleph)000301526FED01 035 $a000301526 100 $a20000920d--------km-y0itay50------ba 101 0 $aita 102 $aIT 200 1 $a<>attività costruttiva nel 1986$fENEL. 210 $aRoma$cENEL$d\s.a\\. 215 $a121 p.$cill., tav. e grafici$d30 cm 676 $aH/2.2213 712 2$aENEL$9 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003015260403321 952 $aH/2.2213 ENE$b10653$fSES 959 $aSES 996 $aAttività costruttiva nel 1986$9467649 997 $aUNINA DB $aING01 LEADER 00787nam0-2200277---450- 001 990009484220403321 005 20120622194113.0 035 $a000948422 035 $aFED01000948422 035 $a(Aleph)000948422FED01 035 $a000948422 100 $a20111115d1965----km-y0itay50------ba 101 0 $afre 102 $aFR 200 1 $aÉléments d'immunologie générale$fR. Fasquelle, P. Barbier 210 $aParis$cMasson et Cie$d1965 215 $a441 p.$cill.$d24 cm 700 1$aFasquelle,$bRobert$0514348 701 1$aBarbier$bPierre$f$0446852 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009484220403321 952 $aE V 2/m$b1308$fDMVCM 959 $aDMVCM 996 $aÉléments d'immunologie générale$9852066 997 $aUNINA